Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients

References

• Centers for Disease Control and PreventionSurveillance Report – HIV/AIDS surveillance in Europe 2012Atlanta, GA, USACenters for Disease Control and Prevention2013
   Google Scholar
• Centro Operativo AIDS dell’Istituto Superiore di Sanità (ISS)Not Ist Super Sanità2013269 Suppl 1347 I
   Google Scholar
• Lombardy RegionTherapeutic and Diagnostic Path for the patient with HIV diseaseMilan, ItalyLombardy Region2011 Decree no 7485. Available from: http://www.sanita.regione.lombardia.it/cs/Satellite?c=Page&childpagename=DG_Sanita/Page/NormativaDetail&pagename=DG_SANWrapper&cid=1213275902673&keyid=3520Accessed April 5, 2014 Italian
   Google Scholar
• MocroftALedergerberBKatlamaCDecline in the AIDS and death rates in the EuroSIDA study: an observational studyLancet20033629377222912853195
   PubMed Web of Science ®Google Scholar
• NakagawaFLodwickRCostagliolaDCalendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in EuropeJ Acquir Immune Defic Syndr201259329429922083070
   PubMed Web of Science ®Google Scholar
• GazzardBGAndersonJBabikerABritish HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008HIV Med20089856360818826546
   PubMed Web of Science ®Google Scholar
• LimaVDHarriganRBangsbergDRThe combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over timeJ Acquir Immune Defic Syndr200950552953619223785
   PubMed Web of Science ®Google Scholar
• Garcia de OlallaPKnobelHCarmonaAGuelarALopez-ColomesJLCaylaJAImpact of adherence and highly active antiretroviral therapy on survival in HIV-infected patientsJ Acquir Immune Defic Syndr200230110511012048370
   PubMed Web of Science ®Google Scholar
• CookeCELeeHYXingSAdherence to antiretroviral therapy in managed care members in the United States: a retrospective claims analysisJ Manag Care Pharm2014201869224372462
   PubMed Web of Science ®Google Scholar
• WeissLFrenchTFinkelsteinRWatersMMukherjeeRAginsBHIV-related knowledge and adherence to HAARTAids Care200315567367912959818
   PubMed Web of Science ®Google Scholar
• KnobelHCarmonaAGrauSPedro-BotetJDiezAAdherence and effectiveness of highly active antiretroviral therapyArch Intern Med19981581719539759698
   PubMedGoogle Scholar
• BackDGattiGFletcherCTherapeutic drug monitoring in HIV infection: current status and future directionsAIDS200216Suppl 1S5S3712035820
   PubMed Web of Science ®Google Scholar
• PretoriusEKlinkerHRosenkranzBThe role of therapeutic drug monitoring in the management of patients with human immunodeficiency virus infectionTher Drug Monit201133326527421566505
   PubMed Web of Science ®Google Scholar
• KhooSHGibbonsSEBackDJTherapeutic drug monitoring as a tool in treating HIV infectionAIDS200115Suppl 5S171S18111816166
   PubMed Web of Science ®Google Scholar
• LiuXMaQZhangFTherapeutic drug monitoring in highly active antiretroviral therapyExpert Opin Drug Saf20109574375820350281
   PubMed Web of Science ®Google Scholar
• AIDSInfoGuidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents Available from: http://aidsinfo.nih.Gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/0Accessed April 4, 2014
   Google Scholar
• LlibreJMCardonaGSantosJRAntiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in SpainClinicoecon Outcomes Res2013521522123723714
   PubMedGoogle Scholar
• TouwDJNeefCThomsonAHVinksAACost-effectiveness of therapeutic drug monitoring: a systematic reviewTher Drug Monit2005271101715665740
   PubMed Web of Science ®Google Scholar
• Ostad HajiEMannKDragicevicAPotential cost-effectiveness of therapeutic drug monitoring for depressed patients treated with citalopramTher Drug Monit201335339640123666582
   PubMed Web of Science ®Google Scholar
• Di BariMBalziDRobertsATPrognostic stratification of older persons based on simple administrative data: development and validation of the “Silver Code,” to be used in emergency department triageJ Gerontol A Biol Sci Med Sci201065215916419349591
   PubMed Web of Science ®Google Scholar
• Ministry of Labour, Health and Social PoliciesAnnual report on the hospitalization activity2005 Available from: http://www.ministerosalute.it/programmazione/sdo/sezDocumenti.jsp?id=148&label=osp
   Google Scholar
• SchneiderEWhitmoreSGlynnKMDominguezKMitschAMcKennaMTRevised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years – United States, 2008MMWR Recomm Rep200857RR–1011219052530
   PubMedGoogle Scholar
• GardnerEMBurmanWJMaraviMEDavidsonAJSelective drug taking during combination antiretroviral therapy in an unselected clinic populationJ Acquir Immune Defic Syndr200540329430016249703
   PubMed Web of Science ®Google Scholar
• LevyAJohnstonKAnnemansLTramarinAMontanerJThe impact of disease stage on direct medical costs of HIV management: a review of the international literaturePharmacoeconomics201028Suppl 1354721182342
   PubMed Web of Science ®Google Scholar
• GeboKAChaissonREFolkemerJGBartlettJGMooreRDCosts of HIV medical care in the era of highly active antiretroviral therapyAIDS199913896396910371178
   PubMed Web of Science ®Google Scholar
• MocroftAYouleMMooreAReasons for modification and discontinuation of antiretrovirals: results from a single treatment centreAIDS200115218519411216926
   PubMed Web of Science ®Google Scholar
• SchoenenbergerJAAragonesAMCanoSMThe advantages of therapeutic drug monitoring in patients receiving antiretroviral treatment and experiencing medication-related problemsTher Drug Monit2013351717723188184
   PubMed Web of Science ®Google Scholar
• BackDJKhooSHGibbonsSEMerryCThe role of therapeutic drug monitoring in treatment of HIV infectionBr J Clin Pharmacol200151430130811318764
   PubMed Web of Science ®Google Scholar
• HiemkeCBaumannPBergemannNAGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011Pharmacopsychiatry2011446195235
   Web of Science ®Google Scholar
• FabbianiMDi GiambenedettoSBraccialeLPharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practiceJ Antimicrob Chemother200964110911719398461
   PubMed Web of Science ®Google Scholar
• TsasisPAdherence assessment to highly active antiretroviral therapyAIDS Patient Care STDS200115310911511313023
   PubMed Web of Science ®Google Scholar
• BangsbergDRPerrySCharleboisEDNon-adherence to highly active antiretroviral therapy predicts progression to AIDSAIDS20011591181118311416722
   PubMed Web of Science ®Google Scholar
• FieldenSJRuschMLYipBNonadherence increases the risk of hospitalization among HIV-infected antiretroviral naive patients started on HAARTJ Int Assoc Physicians AIDS Care (Chic)20087523824418812590
   PubMedGoogle Scholar
• GundaDWKasangCKidenyaBRPlasma concentrations of efavirenz and nevirapine among HIV-infected patients with immunological failure attending a tertiary hospital in North-Western TanzaniaPLoS One201389e7511824058655
   PubMed Web of Science ®Google Scholar
• ArnstenJHDemasPAFarzadeganHAntiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoringClin Infect Dis20013381417142311550118
   PubMed Web of Science ®Google Scholar
• ReeveEWieseMDBenefits of deprescribing on patients’ adherence to medicationsInt J Clin Pharm2014361262924242974
   PubMed Web of Science ®Google Scholar
• GoicoecheaMBestBSeefriedEWagnerGCapparelliEHaubrichRFailure of modified directly observed therapy combined with therapeutic drug monitoring to enhance antiretroviral adherence in a patient with major depressionAIDS Patient Care STDS200620423323716623621
   PubMed Web of Science ®Google Scholar
• FreedbergKAHirschhornLRSchackmanBRCost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patientsJ Acquir Immune Defic Syndr200643Suppl 1S113S11817133193
   PubMed Web of Science ®Google Scholar
• NachegaJBLeisegangRBishaiDAssociation of antiretroviral therapy adherence and health care costsAnn Intern Med20101521182520048268
   PubMed Web of Science ®Google Scholar